These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 31075347

  • 1. The Notch signaling pathway inhibitor Dapt alleviates autism-like behavior, autophagy and dendritic spine density abnormalities in a valproic acid-induced animal model of autism.
    Zhang Y, Xiang Z, Jia Y, He X, Wang L, Cui W.
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug 30; 94():109644. PubMed ID: 31075347
    [Abstract] [Full Text] [Related]

  • 2. The Notch1/Hes1 pathway regulates Neuregulin 1/ErbB4 and participates in microglial activation in rats with VPA-induced autism.
    Deng Y, Ma L, Du Z, Ma H, Xia Y, Ping L, Chen Z, Zhang Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Apr 20; 131():110947. PubMed ID: 38242426
    [Abstract] [Full Text] [Related]

  • 3. The Notch1/Hes1 signaling pathway affects autophagy by adjusting DNA methyltransferases expression in a valproic acid-induced autism spectrum disorder model.
    Li Y, Ma L, Deng Y, Du Z, Guo B, Yue J, Liu X, Zhang Y.
    Neuropharmacology; 2023 Nov 15; 239():109682. PubMed ID: 37543138
    [Abstract] [Full Text] [Related]

  • 4. [Mechanism of valproic acid-induced dendritic spine and synaptic impairment in the prefrontal cortex for causing core autistic symptoms in mice].
    Wang F, Wang L, Xiong Y, Deng J, Lü M, Tang B, Zhang X, Li Y.
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan 20; 42(1):101-107. PubMed ID: 35249876
    [Abstract] [Full Text] [Related]

  • 5. Environmental enrichment attenuates behavioral abnormalities in valproic acid-exposed autism model mice.
    Yamaguchi H, Hara Y, Ago Y, Takano E, Hasebe S, Nakazawa T, Hashimoto H, Matsuda T, Takuma K.
    Behav Brain Res; 2017 Aug 30; 333():67-73. PubMed ID: 28655565
    [Abstract] [Full Text] [Related]

  • 6. Perinatal exposure to BDE-47 exacerbated autistic-like behaviors and impairments of dendritic development in a valproic acid-induced rat model of autism.
    Li Z, You M, Che X, Dai Y, Xu Y, Wang Y.
    Ecotoxicol Environ Saf; 2021 Apr 01; 212():112000. PubMed ID: 33550075
    [Abstract] [Full Text] [Related]

  • 7. Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism.
    Hara Y, Ago Y, Taruta A, Katashiba K, Hasebe S, Takano E, Onaka Y, Hashimoto H, Matsuda T, Takuma K.
    Autism Res; 2016 Sep 01; 9(9):926-39. PubMed ID: 26714434
    [Abstract] [Full Text] [Related]

  • 8. Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism.
    Takuma K, Hara Y, Kataoka S, Kawanai T, Maeda Y, Watanabe R, Takano E, Hayata-Takano A, Hashimoto H, Ago Y, Matsuda T.
    Pharmacol Biochem Behav; 2014 Nov 01; 126():43-9. PubMed ID: 25240644
    [Abstract] [Full Text] [Related]

  • 9. Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.
    Hara Y, Ago Y, Taruta A, Hasebe S, Kawase H, Tanabe W, Tsukada S, Nakazawa T, Hashimoto H, Matsuda T, Takuma K.
    Psychopharmacology (Berl); 2017 Nov 01; 234(21):3217-3228. PubMed ID: 28798977
    [Abstract] [Full Text] [Related]

  • 10. Tactile stimulation improves neuroanatomical pathology but not behavior in rats prenatally exposed to valproic acid.
    Raza S, Harker A, Richards S, Kolb B, Gibb R.
    Behav Brain Res; 2015 Apr 01; 282():25-36. PubMed ID: 25557797
    [Abstract] [Full Text] [Related]

  • 11. Low-frequency repetitive transcranial magnetic stimulation alleviates abnormal behavior in valproic acid rat model of autism through rescuing synaptic plasticity and inhibiting neuroinflammation.
    Xu X, Li F, Liu C, Wang Y, Yang Z, Xie G, Zhang T.
    Pharmacol Biochem Behav; 2024 Jul 01; 240():173788. PubMed ID: 38734150
    [Abstract] [Full Text] [Related]

  • 12. The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism.
    Reza Naghdi M, Ahadi R, Motamed Nezhad A, Sadat Ahmadi Tabatabaei F, Soleimani M, Hajisoltani R.
    Brain Res; 2024 Sep 01; 1838():148963. PubMed ID: 38705555
    [Abstract] [Full Text] [Related]

  • 13. Early Behavioral Abnormalities and Perinatal Alterations of PTEN/AKT Pathway in Valproic Acid Autism Model Mice.
    Yang EJ, Ahn S, Lee K, Mahmood U, Kim HS.
    PLoS One; 2016 Sep 01; 11(4):e0153298. PubMed ID: 27071011
    [Abstract] [Full Text] [Related]

  • 14. Valproic acid exposure sequentially activates Wnt and mTOR pathways in rats.
    Qin L, Dai X, Yin Y.
    Mol Cell Neurosci; 2016 Sep 01; 75():27-35. PubMed ID: 27343825
    [Abstract] [Full Text] [Related]

  • 15. Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid.
    Nicolini C, Ahn Y, Michalski B, Rho JM, Fahnestock M.
    Acta Neuropathol Commun; 2015 Jan 20; 3():3. PubMed ID: 25627160
    [Abstract] [Full Text] [Related]

  • 16. N-acetylcysteine improves autism-like behavior by recovering autophagic deficiency and decreasing Notch-1/Hes-1 pathway activity.
    Zhang YH, Wang T, Li YF, Deng YN, He XL, Wang LJ.
    Exp Biol Med (Maywood); 2023 Jun 20; 248(11):966-978. PubMed ID: 37377100
    [Abstract] [Full Text] [Related]

  • 17. Chronic inhibition of astrocytic aquaporin-4 induces autistic-like behavior in control rat offspring similar to maternal exposure to valproic acid.
    Davoudi S, Rahdar M, Hosseinmardi N, Behzadi G, Janahmadi M.
    Physiol Behav; 2023 Oct 01; 269():114286. PubMed ID: 37402416
    [Abstract] [Full Text] [Related]

  • 18. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
    Elnahas EM, Abuelezz SA, Mohamad MI, Nabil MM, Abdelraouf SM, Bahaa N, Hassan GA, Ibrahim EA, Ahmed AI, Aboul-Fotouh S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun 08; 108():110185. PubMed ID: 33238165
    [Abstract] [Full Text] [Related]

  • 19. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
    Mirza R, Sharma B.
    Brain Res Bull; 2019 Apr 08; 147():36-46. PubMed ID: 30769127
    [Abstract] [Full Text] [Related]

  • 20. Zinc as a therapy in a rat model of autism prenatally induced by valproic acid.
    Cezar LC, Kirsten TB, da Fonseca CCN, de Lima APN, Bernardi MM, Felicio LF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun 08; 84(Pt A):173-180. PubMed ID: 29481896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.